Bloomer Aaron 4

What Happened

• Aaron Bloomer, Chief Financial Officer of Exact Sciences (EXAS), received a grant of 28,063 restricted stock units (reported as a derivative acquisition) on 2026-02-25. The award is shown at $0.00 (no cash purchase price). This is a compensation award (not an open-market purchase or sale).

Key Details

• Transaction date and type: 2026-02-25 — Award/Grant (code A) of 28,063 restricted stock units at $0.00.
• Shares reported on Form 4: 49,185 shares of common stock.
• Restricted stock units reported in aggregate: 32,458 RSUs (each convertible into one share).
• Vesting: RSUs vest in four equal annual installments beginning February 25, 2027.
• Filing: Form 4 was filed 2026-02-27 (timely; within the usual two-business-day reporting window).
• Notes: RSUs are a derivative/compensation vehicle (contingent right to receive common stock upon vesting), not an immediate equity purchase or sale.

Context

• For retail investors: RSU grants are common executive compensation and do not involve an immediate cash outlay or sale; they represent future equity if vesting conditions are met. This filing documents the grant and outstanding holdings but does not by itself indicate buying or selling intent.